SURGICAL-MANAGEMENT OF ERECTILE DYSFUNCTION

Historically, the development of effective oral, intraurethral, and in jectable pharmacological therapies for the management of erectile dysf unction has relegated surgical management to a secondary role. However , certain subpopulations, such as people with diabetes, have demonstra ted a less optimal response to all of these pharmacological approaches . As a result, these populations continue to support a significant rol e for surgical management options in this field. Additionally, young m en who demonstrate a focal arterial occlusive lesion secondary to peni le, pelvic, or perineal trauma are candidates for vascular reconstruct ive surgical options that may potentially reverse the underlying hemod ynamic abnormality. In these patients, surgical treatment options are in fact a first-line therapy.